A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Recruiting

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology ProductsA Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Sponsor:

Hoffmann-La Roche

Code:

NCT05476926

Conditions

Neovascular Age-related Macular Degeneration

Diabetic Macular Edema

Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Central Retinal Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Faricimab

Port Delivery System with Ranibizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Hoffmann-La Roche on 2025-03-25.